-
Survivor Profile
Spreading the WordAn African-American banking pioneer finds fulfillment in increasing prostate cancer awareness.
by Yvonne Lee
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Q&A
Facing the CriticsRoger Ebert finds peace with his appearance following disfiguring cancer surgery.
by Ronni Gordon
-
Get Involved
One Young Survivor Helping AnotherA teen who survived cancer is raising money to help others.
by Yvonne Lee
-
Yesterday & Today
A Touch of MagicElizabeth Montgomery led a bewitching life that was cut short by colorectal cancer in 1995.
by Sue Rochman
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
-
Forward Look
Therapy Unexpectedly Leads to Mental HazeResearchers surprised that radiation may cause “chemobrain.”
by Melissa Weber
-
Forward Look
Age-Old ConditionProstate cancer is diagnosed in an ancient Egyptian mummy.
by Yvonne Lee
-
Forward Look
The Avastin Roller CoasterUps and downs keep coming for Avastin as studies report on its effects for different cancers.
by Sue Rochman
-
Your Cancer Guide
Giving Kids With Cancer What They NeedSupport should include love, normalcy and age-appropriate information.
by Hester Hill Schnipper
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
